The proposal for a European Paediatric Translational Research Infrastructure (EPTRI), developed in the framework of the European call INFRADEV-01-2017, has been presented at the 16th meeting of the European Society for Developmental Perinatal and Pediatric Pharmacology (ESDPPP) Congress, held in Belgium on 20-23 June 2017, in the section “New tools and approaches to further improve paediatric pharmacotherapy and studies “.
ESDPPP is a non-profit association that puts together pharmacologists, clinicians, and scientists to promote research in developmental perinatal and paediatric pharmacology around the world.
The 16th ESDPPP congress has been the occasion to highlight the urgent need to have a Research Infrastructure (RI) dedicated to Paediatrics to cover the gap in scientific research and new technologies affecting the field of paediatric medicinal products.
The EPTRI proposal, coordinated by CVBF-TEDDY and submitted on March 29th, 2017, will represent a complementary RI in the context of the existing RIs to cover the current gaps in paediatric research and to enhance technology-driven paediatric research in discovery and early development phases. EPTRI will gather research groups focused on specific technical and scientific domains in five specialised Platforms and will represent a “one-stop-shop” for advice in paediatric drug development research.
The project can count on a noteworthy partnership, made up of 26 partners from 19 EU/Associated countries.
The evaluation of the project proposals is expected within 5 months from the submission (August 2017). Let’s keep our fingers crossed!
You can find the abstract submitted to the congress here:
https://kuleuvencongres.be/ESDPPP2017/articles/abstracts/Bonifazi
More information about EPTRI is available here : https://www.teddynetwork.net/eptri/
About the Author: mariangela
